Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06452173

Risk Prediction Model for Cerebrovascular Events in Carotid Artery Stenosis

Deep Learning-based Risk Prediction Model for Cerebrovascular Events in Patients With Carotid Artery Stenosis

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Beijing Tiantan Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Atherosclerotic carotid artery stenosis is a major cause of stroke, and early identification of high-risk patients combined with surgical intervention can significantly reduce stroke risk. Currently, stroke risk assessment in patients with carotid artery stenosis primarily relies on imaging indicators such as plaque morphology, composition, and degree of stenosis, with less emphasis on indicators directly related to inflammation, hemodynamics, and plaque instability. Certain circulating metabolites are closely linked to plaque progression and are direct risk factors for stroke. However, there is a lack of stroke risk prediction models for patients with carotid stenosis that incorporate these indicators, and the ability to identify high-risk patients needs improvement. This study proposes using deep learning technology to integrate multidimensional data from plaque imaging, fluid dynamics, circulating metabolomics, and proteomics to construct an accurate prediction model for cerebrovascular events in patients with carotid artery stenosis. Additionally, it aims to explore markers of plaque instability characteristics based on plaque pathology. The study is expected to provide a basis for identifying high-risk patients with carotid artery stenosis, thereby laying the foundation for reducing stroke risk and improving long-term patient outcomes.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPlasmaPlasma levels of metabolites and some proteins will be further determined
DIAGNOSTIC_TESTcarotid high-resolution magnetic resonance imagingDefine plaque composition and morphological characteristics

Timeline

Start date
2024-04-15
Primary completion
2026-10-31
Completion
2026-12-31
First posted
2024-06-11
Last updated
2024-06-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06452173. Inclusion in this directory is not an endorsement.